Thomas M. Cardillo
0000-0002-9427-8358
Publication & Citation Trends
Publications
0 total
Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5–SN38 Antibody–drug Conjugate in Neuroendocrine Prostate Cancer OA
Cited by 59
Semantic Scholar
New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitis. OA
Cited by 134
Semantic Scholar
Anti-CD74 Antibody-Doxorubicin Conjugate, IMMU-110, in a Human Multiple Myeloma Xenograft and in Monkeys OA
Cited by 164
Semantic Scholar
Identification of a Mu-9 (anti-colon-specific antigen-p)-reactive peptide having homology to CA125 (MUC16).
Cited by 1
Semantic Scholar
Anti-CD 74 Antibody-Doxorubicin Conjugate , IMMU-110 , in a HumanMultipleMyeloma Xenograft and inMonkeys
Cited by 1
Semantic Scholar
Evaluation of a MAb-PAM4-defined MUC1 immunoassay as a potentially new diagnostic test for pancreatic cancer
Cited by 0
Semantic Scholar
Synergistic Interaction between Sphingomyelin and Gemcitabine Potentiates Ceramide-Mediated Apoptosis in Pancreatic Cancer OA
Cited by 65
Semantic Scholar
Research Topics
Monoclonal and Polyclonal Antibodies Research
(184)
Radiopharmaceutical Chemistry and Applications
(113)
HER2/EGFR in Cancer Research
(83)
CAR-T cell therapy research
(49)
Glycosylation and Glycoproteins Research
(25)
Affiliations
University of Iowa Hospitals and Clinics
University of Rochester Medical Center
Immunomedics (United States)
Center for Molecular Medicine and Immunology
Gilead Sciences (United States)